Denosumab is a human monoclonal antibody for the treatment of osteoporosis,
treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.
Learn how Prolia® (denosumab) can help in the treatment of postmenopausal
osteoporosis for women at high risk for fracture.
Apr 23, 2015 ... Read about the cancer treatment drug denosumab, otherwise known as Prolia or
Xgeva, including what it is, how it works and possible side ...
PROLIA safely and effectively. See full prescribing information for. PROLIA. Prolia
® (denosumab). Injection, for subcutaneous use. Initial U.S. Approval: 2010.
Denosumab injection is used to treat osteoporosis (thinning of the bones) in
women who have an increased risk for fractures after menopause, and
Denosumab is an NCCN category 1–recommended treatment option for patients
whose breast or prostate cancer has metastasized to bone1 1,2 ,2. Integrated
Watch the XGEVA® (denosumab) mechanism of action video.
Get information about the monoclonal antibody Denosumab, which may be used
to treat secondary bone cancer.
Pictures of Prolia (Denosumab Injection), drug imprint information, side effects for
Easy to read patient leaflet for denosumab. Includes indications, proper use,
special instructions, precautions, and possible side effects.